Yu-Cheng Chiang

Title: Yu-Cheng Chiang: Innovator in Microbial Applications

Introduction

Yu-Cheng Chiang is a prominent inventor based in Taichung, Taiwan. He has made significant contributions to the field of microbiology, particularly in the development of innovative microbial strains for health applications. His work focuses on addressing health issues related to elevated levels of trimethylamine (TMA) and trimethylamine-n-oxide (TMAO).

Latest Patents

Yu-Cheng Chiang holds a patent for the invention titled "LAM1345 isolate, composition including the same and use thereof." This patent discloses an isolated strain of LAM1345, which is deposited at Deutsche Sammlung von Mikroorganismen and Zellkulturen GmbH under an accession number DSM 33510. The patent also details a composition that includes the isolated strain of LAM1345, aimed at reducing TMA and TMAO levels. Furthermore, it outlines the use of this strain for treating diseases associated with elevated TMA and TMAO levels in subjects.

Career Highlights

Chiang is currently associated with Synbio Tech Inc., where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on health and disease management.

Collaborations

Some of his notable coworkers include San-Land Young and Hau-Yang Tsen, who contribute to the collaborative efforts at Synbio Tech Inc. Their combined expertise enhances the innovative environment within the company.

Conclusion

Yu-Cheng Chiang's contributions to microbial applications demonstrate his commitment to innovation in health-related fields. His patent on the LAM1345 isolate showcases the potential for significant advancements in treating conditions linked to TMA and TMAO.